BDD With UDCA Therapy After Laparoscopic Cholecystectomy

• Status: Unknown status
• Trial end date: 2019-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Prospective Study for the Effects of Biphenyl Dimethyl Dicarboxylate and Ursodeoxycolic Acid Therapy on Liver Function and Quality of Life After Laparoscopic Cholecystectomy

Primary endpoint: peak level of postoperative AST (aspartate transaminase) and postoperative ALT (alanine tansaminase)

Secondary endpoint: postoperative GIQLI (Gastrointestinal Quality of Life index) score

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ewha Womans University Mokdong Hospital
• Treatments: 7,7'-dimethoxy-(4,4'-bi-1,3-benzodioxole)-5,5'-dicarboxylic acid dimethyl ester

Criteria

Inclusion Criteria:

• Patients scheduled for surgery due to chronic cholecystitis and acute cholecystitis

Exclusion Criteria:

• Failure to obtain consent

• Under 19 years

• If you have intellectual ability to understand this study

• When performing cholecystectomy with other operations

• Total bilirubin levels> 2 mg / dl

• If you are enrolled in another clinical trial